Published September, 2011
By Masaki Terabe, J. Berzofsky and Jay A. Berzofsky
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

This book will cover primary roles of NKT cells in immunity to cancer, in both mouse tumor models and cancer patients. There are several chapters describing general aspects of NKT cells.

---

Published September, 2011
By Yves Pommier
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

DNA topoisomerases represent an essential family of DNA processing enzymes and a large number of topoisomerase inhibitors are used clinically for the treatment of various human cancers.

---

Published September, 2011
By Derek LeRoith
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

The book will detail the history, successes, and failures of targeted therapies for cancer, with a particular focus on IGF systems and cancer.

---

Published July, 2011
By Neil J. Clendeninn and Krzysztof Appelt
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

Cutting-edge investigators review the current status of the entire field, from the biology of MMPs through the current clinical studies.

---

Published May, 2011
By Howard L. Kaufman, Scott Wadler and Karen Antman
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

This book presents an overview of the development of targeted therapies for the treatment of cancer with an emphasis on clinical application. The volume covers the complexity of the rapidly developing area of targeted therapies for the treatment of patients with cancer.

---

Published January, 2011
By John D. Haley and William John Gullick
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

The epidermal gro wth factor (EGF ) receptor and its downstream signal transduction networks have been implicated in the ontology and maintenance of tumor tissues, which has motivated the discovery and development of molecularly targeted anti-EGF receptor therapies.

---

Published December, 2010
By Manuel Hidalgo, Manuela Hidalgo, Neil J. Clendeninn, S. Gail Eckhardt and Elizabeth Garrett-Mayer
Publisher: Springer (Springer-Verlag New York Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

A practical guide to the design, conduction, analysis and reporting of clinical trials with anticancer drugs.

---

Published December, 2010
By Beverly A. Teicher and Rebecca G. Bagley
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

Significance of Stem Cells to Tumor Development Cancer stem cells remain a controversial topic and the criteria that define cancer stem cells are continuing to evolve.

---

Published December, 2010
By Ulrike Stein, Peter M Schlag, M.M. Eggermont and Ulrike S. Stein
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

This volume provides a biological and pharmacological background for regional cancer therapy, strategies and techniques for regional therapies, and specific indications and results for different tumor entities.

---

Published December, 2010
By Pat Price and Anthony F. Shields
Publisher: Springer (Humana Press Inc.)
Series: Cancer Drug Discovery and Development
Rating:
Availability: Available

A variety of cutting-edge imaging techniques, including their use for best practice, are addressed in this book. The book also provides examples of results found in both pre-clinical and clinical studies. This comprehensive text covers the entire spectrum of in vivo imaging for oncology.

---